A RANDOMIZED, DOUBLE-BLIND TRIAL OF 12 MG VERSUS 6 MG INTRAVENOUS ADENOSINE FOR THE TERMINATION OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

Registry ID

ADENO-SVT-2026-001

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

DR. SETH DAVIS

Last update

2026-06-11

Conditions

• PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT)

Related clinical trials

• MULTI-CENTER, MULTI-NATIONAL, OPEN-LABEL, EFFICACY AND SAFETY STUDY OF ETRIPAMIL NASAL SPRAY IN PEDIATRIC PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
• MULTI-CENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY, AND SAFETY STUDY OF ETRIPAMIL NASAL SPRAY FOR THE TERMINATION OF SPONTANEOUS EPISODES OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

View on source registry